-
The use of synaptic biomarkers in cerebrospinal fluid to differentiate behavioral variant of frontotemporal dementia from primary psychiatric disorders and Alzheimer’s disease
Das, S., van Engelen, M-P. E., Goossens, J., Jacobs, D., Bongers, B., Fieldhouse, J. L. P., Pijnenburg, Y. A. L., Teunissen, C. E., Vanmechelen, E. & Verberk, I. M. W., Dec 2024, In: Alzheimer's Research and Therapy. 16, 1, p. 34 34.Research output: Contribution to journal › Article › Academic › peer-review
-
Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia
Das, S., Goossens, J., Jacobs, D., Dewit, N., Pijnenburg, Y. A. L., in ‘t Veld, S. G. J. G., Teunissen, C. E. & Vanmechelen, E., 1 Dec 2023, In: Alzheimer's Research and Therapy. 15, 1, 62.Research output: Contribution to journal › Article › Academic › peer-review
-
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative Dementias
MIRIADE consortium, 1 Oct 2023, In: MCP : Molecular & cellular proteomics. 22, 10, p. 100629 100629.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
